Can a reresection be avoided after initial en bloc resection for high-risk nonmuscle invasive bladder cancer? A systematic review and meta-analysis

BackgroundThis study aims to evaluate the effectiveness of en bloc resection for patients with nonmuscle invasive bladder cancer (NMIBC) and explore whether a reresection can be avoided after initial en bloc resection.Material and methodsWe conducted research in PubMed, EMBASE, Cochrane Library, and...

Full description

Bibliographic Details
Main Authors: Jiangnan Xu, Zhenyu Xu, HuMin Yin, Jin Zang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Surgery
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fsurg.2022.849929/full
_version_ 1797995090990333952
author Jiangnan Xu
Jiangnan Xu
Zhenyu Xu
HuMin Yin
Jin Zang
author_facet Jiangnan Xu
Jiangnan Xu
Zhenyu Xu
HuMin Yin
Jin Zang
author_sort Jiangnan Xu
collection DOAJ
description BackgroundThis study aims to evaluate the effectiveness of en bloc resection for patients with nonmuscle invasive bladder cancer (NMIBC) and explore whether a reresection can be avoided after initial en bloc resection.Material and methodsWe conducted research in PubMed, EMBASE, Cochrane Library, and Web of Science up to October 12, 2021, to identify studies on the second resection after initial en bloc resection of bladder tumor (ERBT). R software and the double arcsine method were used for data conversion and combined calculation of the incidence rate.ResultsA total of 8 studies involving 414 participants were included. The rate of detrusor muscle in the ERBT specimens was 100% (95%CI: 100%–100%), the rate of tumor residual in reresection specimens was 3.2% (95%CI: 1.4%–5.5%), and the rate of tumor upstaging was 0.3% (95%CI: 0%–1.5%). Two articles compared the prognostic data of the reresection and non-reresection groups after the initial ERBT. We found no significant difference in the 1-year recurrence-free survival (RFS) rate (OR = 1.44, 95%CI: 0.67–3.09, P = 0.35) between the two groups nor in the rate of tumor recurrence (OR = 0.72, 95%CI: 0.44–1.18, P = 0.2) or progression (OR = 0.98, 95%CI: 0.33–2.89, P = 0.97) at the final follow-up.ConclusionsERBT can almost completely remove the detrusor muscle of the tumor bed with a very low postoperative tumor residue and upstaging rate. For high-risk NMIBC patients, an attempt to appropriately reduce the use of reresection after ERBT seems to be possible.
first_indexed 2024-04-11T09:56:00Z
format Article
id doaj.art-209d361ee1a142efbaa27268acc4b7fc
institution Directory Open Access Journal
issn 2296-875X
language English
last_indexed 2024-04-11T09:56:00Z
publishDate 2022-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Surgery
spelling doaj.art-209d361ee1a142efbaa27268acc4b7fc2022-12-22T04:30:37ZengFrontiers Media S.A.Frontiers in Surgery2296-875X2022-09-01910.3389/fsurg.2022.849929849929Can a reresection be avoided after initial en bloc resection for high-risk nonmuscle invasive bladder cancer? A systematic review and meta-analysisJiangnan Xu0Jiangnan Xu1Zhenyu Xu2HuMin Yin3Jin Zang4Department of Urology, Yancheng First Hospital, Affiliated Hospital of Nanjing University Medical School, Yancheng, ChinaDepartment of Urology, The First People’s Hospital of Yancheng, Yancheng, ChinaDepartment of Urology, Kunshan Chinese Medicine Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, ChinaDepartment of Urology, The First Affiliated Hospital of Soochow University, Suzhou, ChinaDepartment of Urology, The First Affiliated Hospital of Soochow University, Suzhou, ChinaBackgroundThis study aims to evaluate the effectiveness of en bloc resection for patients with nonmuscle invasive bladder cancer (NMIBC) and explore whether a reresection can be avoided after initial en bloc resection.Material and methodsWe conducted research in PubMed, EMBASE, Cochrane Library, and Web of Science up to October 12, 2021, to identify studies on the second resection after initial en bloc resection of bladder tumor (ERBT). R software and the double arcsine method were used for data conversion and combined calculation of the incidence rate.ResultsA total of 8 studies involving 414 participants were included. The rate of detrusor muscle in the ERBT specimens was 100% (95%CI: 100%–100%), the rate of tumor residual in reresection specimens was 3.2% (95%CI: 1.4%–5.5%), and the rate of tumor upstaging was 0.3% (95%CI: 0%–1.5%). Two articles compared the prognostic data of the reresection and non-reresection groups after the initial ERBT. We found no significant difference in the 1-year recurrence-free survival (RFS) rate (OR = 1.44, 95%CI: 0.67–3.09, P = 0.35) between the two groups nor in the rate of tumor recurrence (OR = 0.72, 95%CI: 0.44–1.18, P = 0.2) or progression (OR = 0.98, 95%CI: 0.33–2.89, P = 0.97) at the final follow-up.ConclusionsERBT can almost completely remove the detrusor muscle of the tumor bed with a very low postoperative tumor residue and upstaging rate. For high-risk NMIBC patients, an attempt to appropriately reduce the use of reresection after ERBT seems to be possible.https://www.frontiersin.org/articles/10.3389/fsurg.2022.849929/fullhigh-risknonmuscle-invasive bladder canceren bloc resectionreresectionsystematic review and meta-analysis
spellingShingle Jiangnan Xu
Jiangnan Xu
Zhenyu Xu
HuMin Yin
Jin Zang
Can a reresection be avoided after initial en bloc resection for high-risk nonmuscle invasive bladder cancer? A systematic review and meta-analysis
Frontiers in Surgery
high-risk
nonmuscle-invasive bladder cancer
en bloc resection
reresection
systematic review and meta-analysis
title Can a reresection be avoided after initial en bloc resection for high-risk nonmuscle invasive bladder cancer? A systematic review and meta-analysis
title_full Can a reresection be avoided after initial en bloc resection for high-risk nonmuscle invasive bladder cancer? A systematic review and meta-analysis
title_fullStr Can a reresection be avoided after initial en bloc resection for high-risk nonmuscle invasive bladder cancer? A systematic review and meta-analysis
title_full_unstemmed Can a reresection be avoided after initial en bloc resection for high-risk nonmuscle invasive bladder cancer? A systematic review and meta-analysis
title_short Can a reresection be avoided after initial en bloc resection for high-risk nonmuscle invasive bladder cancer? A systematic review and meta-analysis
title_sort can a reresection be avoided after initial en bloc resection for high risk nonmuscle invasive bladder cancer a systematic review and meta analysis
topic high-risk
nonmuscle-invasive bladder cancer
en bloc resection
reresection
systematic review and meta-analysis
url https://www.frontiersin.org/articles/10.3389/fsurg.2022.849929/full
work_keys_str_mv AT jiangnanxu canareresectionbeavoidedafterinitialenblocresectionforhighrisknonmuscleinvasivebladdercancerasystematicreviewandmetaanalysis
AT jiangnanxu canareresectionbeavoidedafterinitialenblocresectionforhighrisknonmuscleinvasivebladdercancerasystematicreviewandmetaanalysis
AT zhenyuxu canareresectionbeavoidedafterinitialenblocresectionforhighrisknonmuscleinvasivebladdercancerasystematicreviewandmetaanalysis
AT huminyin canareresectionbeavoidedafterinitialenblocresectionforhighrisknonmuscleinvasivebladdercancerasystematicreviewandmetaanalysis
AT jinzang canareresectionbeavoidedafterinitialenblocresectionforhighrisknonmuscleinvasivebladdercancerasystematicreviewandmetaanalysis